For many years, world institutions have been trying to unite healthcare stakeholders to solve the issues affecting the drug and vaccine supply chain.
The global COVID-19 pandemic is occurring in an era when the reach of technology allows us to reinvent and deploy more efficient and secure ways to distribute drugs and vaccines to all who need them.
How can we guarantee vaccines are authentic and safe for distribution?
Supplying a vaccine to the global population will pose many challenges, including supply chain security and product verification. A viable solution will need to address issues such as counterfeiting, theft, hijacking and illegal diversion of vaccines.
Track-and-trace technology suppliers, such as OPTEL GROUP, have developed and deployed hardware and data infrastructure to support this and other initiatives to slow down the spread of COVID-19 while putting in place the technological foundation of digital healthcare supply chains to ensure safe and equitable access to life-saving drugs and vaccines now and in the future.
OPTEL’s track-and-trace platform now integrates data analytics and human engagement technologies to answer other challenges in the healthcare supply chain, such as combating gray-market diversion, cold chain monitoring, inventory control, digital recalls, adverse effect reporting, etc.
A single platform, usually deployed by country, captures data along the supply chain to create a control tower for all cases, with dashboards, reporting and alerts, for real-time action on:
OTHER BENEFITS of a digital traceability platform for vaccines:
Dedicated to solving problems, OPTEL develops and implements traceability solutions to help companies achieve greater transparency and efficiency in their supply chains. Are you interested and want to understand more about the traceability solutions that OPTEL offers?
For more than a decade, OPTEL’s L4-L5 serialization software, a patented, enterprise-level serialization and traceability solution, has been helping the world’s best-known brands protect their assets.
As the pharma industry continues to adapt to new challenges and increasing demand for transparency, companies must also equip themselves with the tools to meet expectations while maximizing operational efficiency.
OPTEL has developed powerful tools that can be easily deployed and integrated into your L4 environment to make the most of your manufacturing processes.